English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 11 September 2024, 10:42 HKT/SGT
Share:
    

Source: TR Capital
TR Capital Announces Appointment of Fourth Partner in Drive for Accelerated Growth

- Deepanshu Madan, an Indian national with experience across India and Southeast Asia, becomes the latest partner at Asia’s leading secondary private equity firm

- TR’s India business continues to expand and to capture growing opportunities as one of the first-movers in this space

Singapore and Mumbai, Sept 11, 2024 - (ACN Newswire) - TR Capital, the leading Asian secondary private equity firm, is pleased to announce that Deepanshu Madan has been made the firm’s fourth Partner, marking an important milestone in the firm’s strategic growth.

Deepanshu joined TR Capital seven years ago as a Director, and has since played a pivotal role in the development of the firm’s retail and healthcare portfolio across Asia. In November 2023, he was appointed as the Chief Executive Officer of one of the firm’s portfolio companies, Pharmacity, in Vietnam. At Pharmacity, he is implementing a thorough redesign of the business model to return it to sustainable profitability.

Paul Robine, Founder and CEO of TR Capital, said, “I am thrilled to welcome Deepanshu as our fourth Partner. His exemplary track record over the past seven years, including his exceptional contributions at Pharmacity, underscores the effectiveness of TR’s active investment approach.”

Deepanshu Madan, Partner at TR Capital, said, “I am pleased to be appointed as a Partner at TR Capital and to contribute to the strong investment and ownership culture at the firm. We will continue to push boundaries in developing and supporting our portfolio companies whilst delivering on our active investment approach.”

This new addition to TR Capital’s senior leadership team is a strategic move to bolster the firm’s expansion in key markets, particularly in India. Recent initiatives, including leading the innovative Samara Capital continuation fund and the Fibe secondary direct deal, highlight TR's commitment to advancing its market presence.

In accordance with its growth strategy, TR Capital has recently realigned its local teams at the Director and VP levels to ensure it remains attuned to the dynamics of each local market.

Mr. Robine further commented, “The global secondary market landscape is evolving rapidly, particularly in India, where smaller secondary funds are surfacing alongside established players like TR Capital, creating an increasingly dynamic industry. As a pioneer in this sector, we take great pride in our innovative contributions to the Indian market and look forward to continued success in the future.”

About TR Capital

TR Capital is a leading secondary private equity investor in the Asia-Pacific region, providing liquidity solutions to owners of private equity assets through single asset and portfolio transactions. 

The firm makes significant investments in innovative leaders in the Technology, Next-Generation Consumer and Healthcare sectors across Asia. TR Capital is an active investor and shareholder and works with its portfolio companies to optimize their business models and capital structures. 

TR Capital currently manages funds with aggregate capital commitments of close to US$1.5 billion. The firm’s sophisticated investor base includes sovereign funds, pension funds, asset management firms, entrepreneurs, and family offices.

For more information, please contact:

Artemis Associates

Diana Footitt, CEO

diana.footitt@artemisassociates.com

+852 9183 0667

Dan Bradley, Managing Director

dan.bradley@artemisassociates.com

+852 6145 7455

Bowen Chui, Director

bowen.chui@artemisassociates.com

+852 9783 0643

 



Topic: Press release summary
Source: TR Capital

Sectors: Funds & Equities
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
Kincora and AngloGold Ashanti Exploration Expands and Upgrades Nevertire with Drilling Recommenced  
Feb 10, 2026 19:29 HKT/SGT
EssexBio Bolsters Commitment to Ophthalmology Innovation at APAO 2026 in Hong Kong  
Feb 10, 2026 18:14 HKT/SGT
"> Honda Works Partner Aston Martin Aramco Formula One(TM) Team Unveils Livery of "AMR26" F1(TM) Machine Equipped with Honda Power Unit Ahead of the 2026 Race Season
  
Tuesday, February 10, 2026 5:25:00 PM
CTF Life+ Announces Winners of Financial Empowerment Case Competition, Innovative Platform Advances Intergenerational Inclusion  
Feb 10, 2026 17:02 HKT/SGT
Honda to Make Organizational Changes to Further Enhance Competitiveness its Motorcycle, Automobile and Power Products Business  
Tuesday, February 10, 2026 4:53:00 PM
KS Energy and Hitachi Collaborate on Extra-High Voltage Battery Energy Storage System  
Tuesday, February 10, 2026 1:15:00 PM
Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Designated for Priority Review in China  
Tuesday, February 10, 2026 12:34:00 PM
Spritzer EcoPark Gallops into the Year of the Horse with a Tradition-Inspired Chinese New Year Celebration  
Feb 10, 2026 11:49 HKT/SGT
Mint Signed MoU with Robotics Leader Rice Robotics to Pioneer Physical AI Solutions Across Asia  
Feb 10, 2026 09:43 HKT/SGT
NEC Exhibits at MWC Barcelona 2026, the World's Largest Mobile-Related Exhibition  
Monday, February 9, 2026 8:18:00 PM
More Press release >>
 Events:
More events >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575